Journal scan

Antibodies increase the risk of poor outcome for patients with autoimmune hepatitis

The presence of antibodies for the soluble liver antigen/liver pancreas antigen (SLA/LP) is a major risk factor for poor outcomes in patients with autoimmune hepatitis, say German researchers.

This article is for subscribers only

Jobs